Erminia Massarelli
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Immunology top 5%
- Cancer Research top 2%
- Co-authors
- Roy S. HerbstIgnacio I. WistubaXiming TangDiane D. LiuAna C. XavierMarileila Varella‐GarciaNatalie OzburnVassiliki A. Papadimitrakopoulou
- Topics
- Lung Cancer Treatments and Mutations (71 papers)Cancer Immunotherapy and Biomarkers (44 papers)Lung Cancer Research Studies (33 papers)
- Journals
- Journal of Clinical InvestigationJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Erminia Massarelli
135 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 3.2k
- Pulmonary and Respiratory Medicine 2.1k
- Molecular Biology 1.2k
- Immunology 729
- Cancer Research 648
Countries citing papers authored by Erminia Massarelli
This map shows the geographic impact of Erminia Massarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erminia Massarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erminia Massarelli more than expected).
Fields of papers citing papers by Erminia Massarelli
This network shows the impact of papers produced by Erminia Massarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erminia Massarelli. The network helps show where Erminia Massarelli may publish in the future.
Co-authorship network of co-authors of Erminia Massarelli
This figure shows the co-authorship network connecting the top 25 collaborators of Erminia Massarelli. A scholar is included among the top collaborators of Erminia Massarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erminia Massarelli. Erminia Massarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 9 | |
| 10 | 115 | |
| 11 | 0 | |
| 12 | 24 | |
| 13 | 1 | |
| 14 | 9 | |
| 15 | Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Studybreakdown → | 497 |
| 16 | 251 | |
| 17 | 11 | |
| 18 | 68 | |
| 19 | 187 | |
| 20 | 71 |
About Erminia Massarelli
Erminia Massarelli is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 140 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (71 papers), Cancer Immunotherapy and Biomarkers (44 papers) and Lung Cancer Research Studies (33 papers). The work is most often cited by research in Otorhinolaryngology (551 citations), Oncology (3.2k citations) and Pulmonary and Respiratory Medicine (2.1k citations). Erminia Massarelli has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Roy S. Herbst, Ignacio I. Wistuba, Ximing Tang, Diane D. Liu, Ana C. Xavier, Marileila Varella‐Garcia, Natalie Ozburn, Vassiliki A. Papadimitrakopoulou, B. Nebiyou Bekele and Ravi Salgia. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.